Delivery Order SPE2DB20D2104-SPE2DB25FMVAD
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of CIBINQO 100 mg tablets in 30-count units. This firm fixed-price delivery order, valued at $9,258.33 with a completion date of May 5, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Cibinqo 100 mg tablets in quantities of 30 units, with a ceiling value of $5,114.08. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 28, 2025....
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Cibinqo 100 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $7,742.67 and an ultimate completion date of June 2, 2025. The contract was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- This federal contract award, valued at $3,400.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order that provides for the delivery of CIBINQO 100 MG TABLET UU 30S, a pharmaceutical product, with a completion date of January 17, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $4,027.02 delivery order to AmerisourceBergen Drug Corp for Quilpta 60 mg tablets (30-count package) on August 1, 2025, with an ultimate completion date of August 4, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 1, 2025, for the supply of Qualiptа 60 mg tablets (30-count units) under a firm fixed price contract with a ceiling value of $3,728.78 and an ultimate completion date of April 2, 2025. This non-competitive delivery order represents a single pharmaceutical supply transaction executed through the company's existing contract vehicle with DLA. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a $1,154.79 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Qualiptia 60 mg, with an ultimate completion date of July 17, 2025. This non-set-aside contract was competitively awarded and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The award reflects routine federal pharmaceutical procurement to support military and veteran healthcare systems through the Defense...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 23, 2025, valued at $10,238.74 for INQOVI 35 MG-100 MG tablets (55 units) through the Defense Logistics Agency. The contract is a firm fixed price delivery order with an ultimate completion date of October 15, 2025, and represents a competitively awarded, non-set-aside procurement. This delivery order is issued under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a firm fixed-price delivery order valued at $44,828.08 to AmerisourceBergen Drug Corp (CAGE 0U9U0), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This non-set-aside competitive award, issued on July 14, 2025, with an ultimate completion date of July 15, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for TRUQAP 160 mg tablets on July 10, 2025, with a ceiling value of $15,658.94 and ultimate completion by July 31, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMVADDelivery Order
The Defense Logistics Agency awarded a $4,060.89 delivery order to AmerisourceBergen Drug Corp for CIBINQO 100 mg tablets (30-count units) with a completion deadline of July 9, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA supply chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies supporting military healthcare programs worldwide. Through this flexible contract vehicle, AmerisourceBergen serves multiple government healthcare customers including the Defense Health Agency and U.S. Coast Guard, positioning itself as a key supplier within the DLA's pharmaceutical procurement infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 7/8/25 |